Get started
BEIJING SCIENCE SUBB

BEIJING SCIENCE SU

14.40CNYD
+0.21+1.48%
As of today at 05:20 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

300485 fundamentals

Key facts

Market capitalization‪7.08 B‬CNY
Dividend yield (indicated)0.00%
Price to earnings Ratio (TTM)42.26
Basic EPS (TTM)0.34CNY
Founded1999
Employees (FY)513
CEOBiao Ma
Websitessyy.com.cn
About

Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. It offers natural or biotechnology products for the treatment of cardiovascular and cerebrovascular diseases as well as two-way immunomodulatory. The company was founded on May 20, 1999 and is headquartered in Beijing, China.

Ownership
‪‪481.67 M‬‬
Free Float shares
‪‪368.36 M‬‬ (76.48%)
Closely held shares
‪‪113.31 M‬‬ (23.52%)
Free Float shares
‪‪368.36 M‬‬ (76.48%)
Closely held shares
‪‪113.31 M‬‬ (23.52%)
Capital structure
Market cap
‪‪7.08 B‬‬
Minority interest
‪‪27.23 M‬‬
Cash & equivalents
‪‪1.61 B‬‬
Enterprise value
‪‪5.50 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪7.08 B‬‬
Price to earning ratio (P/E)
42.26x
Price to sales ratio (P/S)
17.44x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
42.26x
Price to sales ratio (P/S)
17.44x
Valuation ratios
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−270%‬
‪−180%‬
‪−90%‬
‪0%‬
‪90%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−200.00 M‬‬
‪‪−100.00 M‬‬
‪0.00‬
‪‪100.00 M‬‬
‪‪200.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Cardiovascular and Cerebrovascular Medications
Immune System Medications
Nervous System Medications
Other Medicines, Other
By country
Period: 2024
China

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
0.15%
Last payment
0.022
Last ex-date
May 29, 2024
Last pay date
May 29, 2024
Dividend history
‪0.00%‬
‪0.35%‬
‪0.70%‬
‪1.05%‬
‪1.40%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.04‬
‪0.09‬
‪0.14‬
‪0.18‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−45.00 M‬‬
‪0.00‬
‪‪45.00 M‬‬
‪‪90.00 M‬‬
‪‪135.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Assets
Liabilities